Workflow
灵康药业(603669) - 2021 Q3 - 季度财报
LioncoLionco(SH:603669)2021-10-29 16:00

Financial Performance - The company's operating revenue for Q3 2021 was CNY 176,044,813.85, a decrease of 40.57% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2021 was CNY 10,102,189.45, down 86.72% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 5,753,668.90, a decline of 77.60% compared to the previous year[5]. - The basic earnings per share for Q3 2021 was CNY 0.01, a decrease of 90.91% from the same period last year[6]. - The weighted average return on equity for Q3 2021 was 0.69%, a decrease of 4.97 percentage points year-on-year[6]. - The net profit for the year-to-date was CNY 78,884,394.04, down 48.22% compared to the same period last year[5]. - Total operating revenue for the first three quarters of 2021 was CNY 653,972,322.58, a decrease of 15.1% compared to CNY 769,993,995.94 in the same period of 2020[19]. - Net profit for the first three quarters of 2021 was CNY 78,884,394.04, a decline of 48.2% from CNY 152,359,597.78 in the same period of 2020[20]. - The company reported a total profit of CNY 91,256,457.38 for the first three quarters of 2021, down 46.5% from CNY 169,941,654.48 in the previous year[20]. - Other income for the first three quarters of 2021 was CNY 24,252,019.56, a significant decrease from CNY 87,793,401.54 in the previous year[19]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,695,794,485.52, a decrease of 0.75% from the end of the previous year[6]. - As of September 30, 2021, total assets amounted to RMB 2,695,794,485.52, a slight decrease from RMB 2,716,208,544.25 at the end of 2020[15]. - Current assets totaled RMB 2,015,644,139.68, compared to RMB 2,038,816,387.03 at the end of 2020, indicating a decrease of approximately 1.4%[16]. - Total liabilities decreased slightly to RMB 1,224,423,387.15 from RMB 1,236,333,673.38, a reduction of about 1%[17]. - The company's equity attributable to shareholders was RMB 1,471,371,098.37, down from RMB 1,479,874,870.87, indicating a decrease of approximately 0.6%[17]. - The total liabilities included short-term borrowings of 389,746,221.99 RMB, unchanged from the previous period[27]. - The company's total equity stood at approximately $1.48 billion, with paid-in capital of $713.44 million and retained earnings of $327.62 million[28]. - The total liabilities and equity amounted to CNY 2,695,794,485.52 as of the end of the reporting period[18]. - The total liabilities and equity combined were approximately $2.718 billion, indicating a balanced financial structure[28]. Cash Flow - The cash flow from operating activities for the year-to-date was CNY -6,423,057.02, reflecting a significant decline[6]. - The net cash flow from operating activities was -6,423,057.02 RMB, a decrease from 21,215,904.94 RMB in the previous quarter[24]. - Total cash inflow from investment activities was 1,111,232,123.41 RMB, compared to 656,386,626.08 RMB in the previous quarter[24]. - The net cash flow from investment activities was -603,007,209.64 RMB, a decline from 209,087,254.20 RMB in the previous quarter[24]. - Cash inflow from financing activities totaled 482,793,377.72 RMB, up from 383,664,091.64 RMB in the previous quarter[25]. - The net cash flow from financing activities was 19,628,221.60 RMB, compared to 207,661,556.85 RMB in the previous quarter[25]. - The ending cash and cash equivalents balance was 964,807,350.04 RMB, slightly up from 925,992,921.30 RMB in the previous quarter[25]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,368[12]. - The number of shares held by the largest shareholder, Lingkang Holdings Group Co., Ltd., is 339,652,800, representing 47.10% of total shares[13]. Operational Challenges - The company attributed the revenue decline primarily to centralized procurement and nationwide price linkage impacts[10]. - The company reported a significant cash outflow in operating activities, indicating potential liquidity challenges[24]. - The company has not disclosed any new product developments or market expansion strategies in the current report[14]. Research and Development - Research and development expenses for the first three quarters of 2021 were CNY 18,658,295.54, an increase of 44.3% compared to CNY 12,969,101.39 in the same period of 2020[19]. Accounting Standards - The company implemented a new leasing standard effective January 1, 2021, which did not significantly impact financial results or cash flows[29]. - There were no significant adjustments or retrospective changes affecting the financial statements[29].